Patent · US Active

Method for in vitro diagnosis or prognosis of testicular cancer

US10240213B2 · kind B2 · utility

0Cited by
1References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 11, 2013
Grant dateMar 26, 2019
Priority date
Expiry dateMay 9, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to a method for in vitro diagnosis or prognosis of testicular cancer which comprises a step of detecting the presence or absence of at least one expression product from at least one nucleic acid sequence selected from the sequences identified in SEQ ID NOS: 1 to 6 or from the sequences which exhibit at least 99% identity with one of the sequences identified in SEQ ID NOS: 1 to 6, to isolated nucleic acid sequences and to the use thereof as a testicular cancer marker.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.